Kymera Therapeutics Stock Forecast - Naive Prediction
| KYMR Stock | USD 74.77 0.21 0.28% |
The Naive Prediction forecasted value of Kymera Therapeutics on the next trading day is expected to be 71.34 with a mean absolute deviation of 3.12 and the sum of the absolute errors of 190.13. Kymera Stock Forecast is based on your current time horizon. Although Kymera Therapeutics' naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Kymera Therapeutics' systematic risk associated with finding meaningful patterns of Kymera Therapeutics fundamentals over time.
As of today the rsi of Kymera Therapeutics' share price is below 20 . This indicates that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.89) | EPS Estimate Current Year (3.46) | EPS Estimate Next Year (3.69) | Wall Street Target Price 116.7619 | EPS Estimate Current Quarter (0.79) |
Using Kymera Therapeutics hype-based prediction, you can estimate the value of Kymera Therapeutics from the perspective of Kymera Therapeutics response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Kymera Therapeutics using Kymera Therapeutics' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Kymera using crowd psychology based on the activity and movement of Kymera Therapeutics' stock price.
Kymera Therapeutics Short Interest
An investor who is long Kymera Therapeutics may also wish to track short interest. As short interest increases, investors should be becoming more worried about Kymera Therapeutics and may potentially protect profits, hedge Kymera Therapeutics with its derivative instruments, or be ready for some potential downside.
200 Day MA 49.3141 | Short Percent 0.1188 | Short Ratio 5.76 | Shares Short Prior Month 8.7 M | 50 Day MA 71.7088 |
Kymera Therapeutics Hype to Price Pattern
Investor biases related to Kymera Therapeutics' public news can be used to forecast risks associated with an investment in Kymera. The trend in average sentiment can be used to explain how an investor holding Kymera can time the market purely based on public headlines and social activities around Kymera Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of Kymera Therapeutics' market sentiment to its price can help taders to make decisions based on the overall investors consensus about Kymera Therapeutics.
Kymera Therapeutics Implied Volatility | 1.14 |
Kymera Therapeutics' implied volatility exposes the market's sentiment of Kymera Therapeutics stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Kymera Therapeutics' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Kymera Therapeutics stock will not fluctuate a lot when Kymera Therapeutics' options are near their expiration.
The Naive Prediction forecasted value of Kymera Therapeutics on the next trading day is expected to be 71.34 with a mean absolute deviation of 3.12 and the sum of the absolute errors of 190.13. Kymera Therapeutics after-hype prediction price | USD 74.77 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Check out Historical Fundamental Analysis of Kymera Therapeutics to cross-verify your projections. Open Interest Against 2026-02-20 Kymera Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Kymera Therapeutics' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Kymera Therapeutics' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Kymera Therapeutics stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Kymera Therapeutics' open interest, investors have to compare it to Kymera Therapeutics' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Kymera Therapeutics is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Kymera. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Kymera Therapeutics Additional Predictive Modules
Most predictive techniques to examine Kymera price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Kymera using various technical indicators. When you analyze Kymera charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kymera Therapeutics Cash Forecast
Forecasting financial indicators like cash flow involves analysts applying various statistical methods, techniques, and algorithms. These tools reveal hidden trends within the Kymera Therapeutics' financial statements to estimate their effects on upcoming price movements.
Cash | First Reported 2019-12-31 | Previous Quarter 335.8 M | Current Value 112.9 M | Quarterly Volatility 63.1 M |
Kymera Therapeutics Naive Prediction Price Forecast For the 12th of January 2026
Given 90 days horizon, the Naive Prediction forecasted value of Kymera Therapeutics on the next trading day is expected to be 71.34 with a mean absolute deviation of 3.12, mean absolute percentage error of 19.87, and the sum of the absolute errors of 190.13.Please note that although there have been many attempts to predict Kymera Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Kymera Therapeutics' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Kymera Therapeutics Stock Forecast Pattern
| Backtest Kymera Therapeutics | Kymera Therapeutics Price Prediction | Buy or Sell Advice |
Kymera Therapeutics Forecasted Value
In the context of forecasting Kymera Therapeutics' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Kymera Therapeutics' downside and upside margins for the forecasting period are 65.36 and 77.33, respectively. We have considered Kymera Therapeutics' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Naive Prediction forecasting method's relative quality and the estimations of the prediction error of Kymera Therapeutics stock data series using in forecasting. Note that when a statistical model is used to represent Kymera Therapeutics stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 121.0999 |
| Bias | Arithmetic mean of the errors | None |
| MAD | Mean absolute deviation | 3.1168 |
| MAPE | Mean absolute percentage error | 0.0437 |
| SAE | Sum of the absolute errors | 190.1256 |
Predictive Modules for Kymera Therapeutics
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Kymera Therapeutics. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for Kymera Therapeutics
For every potential investor in Kymera, whether a beginner or expert, Kymera Therapeutics' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Kymera Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Kymera. Basic forecasting techniques help filter out the noise by identifying Kymera Therapeutics' price trends.Kymera Therapeutics Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Kymera Therapeutics stock to make a market-neutral strategy. Peer analysis of Kymera Therapeutics could also be used in its relative valuation, which is a method of valuing Kymera Therapeutics by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Kymera Therapeutics Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Kymera Therapeutics' price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Kymera Therapeutics' current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Kymera Therapeutics Market Strength Events
Market strength indicators help investors to evaluate how Kymera Therapeutics stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Kymera Therapeutics shares will generate the highest return on investment. By undertsting and applying Kymera Therapeutics stock market strength indicators, traders can identify Kymera Therapeutics entry and exit signals to maximize returns.
Kymera Therapeutics Risk Indicators
The analysis of Kymera Therapeutics' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Kymera Therapeutics' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting kymera stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.85 | |||
| Semi Deviation | 2.57 | |||
| Standard Deviation | 5.87 | |||
| Variance | 34.48 | |||
| Downside Variance | 9.33 | |||
| Semi Variance | 6.62 | |||
| Expected Short fall | (3.26) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Pair Trading with Kymera Therapeutics
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Kymera Therapeutics position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Kymera Therapeutics will appreciate offsetting losses from the drop in the long position's value.Moving against Kymera Stock
The ability to find closely correlated positions to Kymera Therapeutics could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Kymera Therapeutics when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Kymera Therapeutics - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Kymera Therapeutics to buy it.
The correlation of Kymera Therapeutics is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Kymera Therapeutics moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Kymera Therapeutics moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Kymera Therapeutics can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Additional Tools for Kymera Stock Analysis
When running Kymera Therapeutics' price analysis, check to measure Kymera Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Kymera Therapeutics is operating at the current time. Most of Kymera Therapeutics' value examination focuses on studying past and present price action to predict the probability of Kymera Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Kymera Therapeutics' price. Additionally, you may evaluate how the addition of Kymera Therapeutics to your portfolios can decrease your overall portfolio volatility.